MAN0009593 TaqManSNP UG
MAN0009593 TaqManSNP UG
MAN0009593 TaqManSNP UG
USER GUIDE
Single-tube assays
Corporate entity: Life Technologies Corporation | Carlsbad, CA 92008 USA | Toll Free in USA 1 800 955 6288
Important Licensing Information: These products may be covered by one or more Limited Use Label Licenses. By use of these products, you accept
the terms and conditions of all applicable Limited Use Label Licenses.
TRADEMARKS: All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. TaqMan and AmpliTaq
Gold are trademarks of Roche Molecular Systems, Inc., TaqMan is used under permission and license. DNAzol is a trademark of Molecular Research
Center, Inc. Oragene is a trademark of DNA Genotek, Inc. NanoDrop is a trademark of NanoDrop Technologies, LLC. Microsoft Excel is a trademark of
Microsoft Corporation.
©2017 Thermo Fisher Scientific Inc. All rights reserved.
Contents
■ CHAPTER 2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
Procedural guidelines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
Before you begin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Extract and purify genomic DNA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Quantify the sample gDNA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Prepare assays, DNA samples, and master mix . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Set up the PCR reactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Select the DNA delivery method . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Set up the PCR reactions: wet DNA method . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Set up the PCR reactions: dried‑down DNA method . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
(Recommended) Perform a pre‑PCR plate read . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
Perform PCR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
Perform the post-PCR plate read and analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
®
Data analysis with TaqMan Genotyper Software . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Data analysis with the Thermo Fisher Cloud Genotyping Application . . . . . . . . . . . . . . 25
Allelic discrimination plots . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
■ APPENDIX A Troubleshooting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
Troubleshooting the AD plot . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
Troubleshooting the AD plot: genetic characteristics of the assay and/or the samples . . 35
Low allele frequency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
Deletion alleles in an individual . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
Additional SNP present under a probe or primer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
Gene has a copy number polymorphism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
SNP is triallelic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
Gene on the X chromosome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
Gene on the Y chromosome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
Troubleshooting the AD plot: sample preparation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
Degraded DNA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
PCR inhibitors in sample . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
Troubleshooting the AD plot: assay preparation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
Reagents mishandled or expired . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
™
Using a master mix without ROX dye . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
DNA or assay reagent not added to the reaction well . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
Insufficient DNA added to the reaction well . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
Evaporation from the reaction well . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
Pipetting errors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
Inefficient mixing or centrifugation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
Assay has high background fluorescence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
More than one sample in the well . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
More than one assay in the well . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
Troubleshooting the AD plot: instrument set-up and maintenance . . . . . . . . . . . . . . . . . . . . 51
Routine instrument maintenance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
Instrument calibration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
Types of calibration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
Troubleshooting the AD plot: data analysis (software) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
Empty allelic discrimination plots . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
No alleles called in the AD plot . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
Homozygous allele frequencies reversed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
Too many alleles called in AD plot . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
■ APPENDIX C Safety . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
Chemical safety . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
Biological hazard safety . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
IMPORTANT! Before using this product, read and understand the information in the
“Safety” appendix in this document.
Context sequence Reporter dye information for the TaqMan® SNP and DME Genotyping Assays are
representation represented in the assay context sequence. The context sequence is the nucleotide
sequence surrounding the SNP site and is provided in the (+) genome strand
orientation relative to the NCBI reference genome. The SNP alleles are included in
brackets, where the order of the alleles corresponds to the association with probe
reporter dyes, where [Allele 1 = VIC™ dye / Allele 2 = FAM™ dye].
If the context sequence is ...XXXXX[A/B]XXXXX...:
• A allele always represents the VIC™ dye
• B allele always represents the FAM™ dye
VIC™‑associated FAM™‑associated
Context sequence clip SNP alleles
allele allele
...CCCACCCTTC[G/A]ACACTATTAC... [G/A] G A
...ATTAACCCAT[T/C]AGTGATGGGG... [T/C] T C
...AAGCAACTAT[G/A]TTCATAACTT... [G/A] G A
...AACCGTGTGA[T/C]GGCAGTGATT... [T/C] T C
The context sequence for your assay is provided in the Assay Information File,
available at thermofisher.com/taqmanfiles.
Compatible All TaqMan® SNP Genotyping Assays are optimized for use with TaqMan®
master mixes Genotyping Master Mix and require only three components for PCR.
• 1–20 ng purified genomic DNA per well (final concentration: ³0.2 ng/µL)
• 20X, 40X, or 80X TaqMan® SNP Genotyping Assay (depending on product and
assay scale)
• TaqMan® Genotyping Master Mix, or another compatible master mix
Table 3 Compatible master mixes for use with TaqMan® SNP Genotyping Assays
®
TaqMan Drug Metabolism Genotyping Assays
TaqMan® Drug Metabolism Genotyping Assays (DME Genotyping Assays) offer a
comprehensive collection of inventoried assays that are optimized for genotyping
SNPs, insertions and deletions (indels), and multi‑nucleotide polymorphisms (MNPs)
in drug metabolism‑related genes. TaqMan® DME Genotyping Assays are available in
small‑scale and are inventoried for fast availability.
TaqMan® DME Genotyping Assays detect potentially causative polymorphisms in 221
drug metabolism enzyme and associated transporter genes. Assays are tested using
genomic DNA from 45 individuals from each of four ethnicities. The minor allele
frequency for each population is available, but rare and mutant alleles may not be
present in the test DNA.
See thermofisher.com/taqmandme for more information.
DME assays: For the list of inventoried TaqMan® DME Genotyping Assays, visit thermofisher.com/
single‑tube taqmandme.
TaqMan® DME Genotyping Assays can also be ordered through the DME Index
(thermofisher.com/taqmandme). The DME Index contains a comprehensive list of the
DME assays with annotations that include:
• The gene to which the polymorphism location is mapped
• Allele nomenclature (from public allele nomenclature sites, when available)
• Polymorphism (for example, A/G)
• Context sequence
• Amino acid change (if applicable)
• Thermo Fisher Scientific MAF data
Custom assays: Custom TaqMan® SNP Genotyping Assays are designed, synthesized, and receive
single‑tube analytical quality control based on sequence information supplied. All information
supplied is secure and confidential. For more information, visit thermofisher.com/
taqmancustomsnp.
Note: For detailed instructions on how to design and order Custom TaqMan® SNP
Genotyping Assays, consult the Custom TaqMan® Assays Design and Ordering Guide
(Pub. No. 4367671). Custom SNP Assays are designed using the Custom Assay Design
Tool (CADT)(thermofisher.com/taqmansnpdesign). This tool may also be used to
upload assays that have already been designed outside the system.
Plate products For projects that require analyzing many samples or for evaluating samples for many
and formats SNP assays can be ordered in plated formats.
Format Source
Storage and Note: For plate formats, see the documentation included with your shipment for
stability storage and stability information.
• Store single‑tubeTaqMan® SNP Genotyping Assays at –25 to –15°C in the dark.
IMPORTANT! Protect TaqMan® Assays from direct exposure to light. Excessive
exposure to light may affect the fluorescent probes.
1. Dilute 40X or 80X TaqMan® SNP Genotyping Assays to a 20X working stock with
1X TE buffer.
Note: 1X TE buffer composition: 10‑mM Tris‑HCl, 1 mM EDTA, pH 8.0, in
DNase‑free, sterile-filtered water.
3. Store multiple aliquots of the TaqMan® SNP Genotyping Assays at –25 to –15°C
in the dark.
[1] We recommend pre-amplifying all samples prepared with the TaqMan® Sample-to-SNP™ Kit when using OpenArray™ for subsequent
genotyping.
7900HT Fast Real-Time PCR Instrument 96-well, 96-well Fast, and 384-well Contact your local
sales office.
StepOne™ Real-Time PCR
System/StepOnePlus™ Real-Time PCR StepOne™ 48-well and 8-strip tubes
System
QuantStudio™ 3 Real-Time PCR System 96-well, 96-well Fast, and 8-strip tubes
Item Source
Equipment
Microcentrifuge MLS
Item Source
Additional reagents
Workflow
Set up the PCR reactions: wet DNA OR Set up the PCR reactions:
method (page 19) dried‑down DNA method (page 21)
Procedural guidelines
• Store TaqMan® SNP Genotyping Assays frozen and away from light until use.
Excessive exposure to light may affect the fluorescent probes.
• Do not perform more than 10 freeze‑thaw cycles.
• To ensure optimal analysis and troubleshooting of the TaqMan® SNP Genotyping
Assays, prepare an optical reaction plate containing the following for each assay.
Quantify the Use one of the following methods to quantify sample gDNA before using TaqMan®
sample gDNA SNP Genotyping Assays:
• UV/Vis spectrophotometry [A260 /A280 measurement (see “UV spectroscopy“ on
page 62)
• NanoDrop™ spectrophotometry
• RNase P method (see “Absolute quantification“ on page 63)
• Qubit™ 3.0 Fluorometer (Cat. No. Q33216) with Qubit™ Assay Tubes (Cat.
No. Q32856) and Qubit™ dsDNA HS Assay Kit (Cat. Nos. Q32851 and Q32854)
See “DNA quantification“ on page 61 for more information.
Prepare assays, • Dilute the 40X or 80X Predesigned and Custom TaqMan® SNP Genotyping
DNA samples, and Assays to a 20X working stock solution (see “Dilute, then dispense aliquots of
TaqMan® SNP Genotyping Assays“ on page 13).
master mix
Note: TaqMan® DME Genotyping Assays are supplied at a 20X concentration.
Select the DNA TaqMan® SNP Genotyping Assays can be used with either wet or dried‑down DNA.
delivery method Drying down the gDNA in plates is the most convenient method for an experiment
that requires multiple plates using the same gDNA or for multiple experiments that
use the same gDNA.
Note: For both methods, it is recommended to use a calibrated, positive‑displacement
pipette to minimize contamination and error.
Set up the PCR IMPORTANT! This procedure is optimized for TaqMan® Genotyping Master Mix. See
reactions: wet Table 13 on page 17 for alternative master mixes and plate and cycling conditions.
DNA method
Prepare the reaction mix: wet DNA method
1. Calculate the number of reactions to be performed for each assay, including
recommended controls (see Table 12 on page 17).
Note: Multiple assays can be run on one reaction plate. Controls for each assay
must be included on the same plate.
2. Combine the following components for the number of reactions required, plus
10% overage.
4. Centrifuge briefly to bring the reaction mix to the bottom of the tube and
eliminate air bubbles.
2. Add the appropriate volume of reaction mix to each well of the reaction plate
(see Table 15 on page 20).
3. Seal the plate with adhesive film, then centrifuge briefly to bring the reaction mix
to the bottom of the well and eliminate air bubbles.
A non‑optical seal can be used for this step.
4. Remove adhesive film from the plate, then add the appropriate volume of
sample or control to the wells. Be sure to include wells for use as no template
controls.
5. Seal the plate with adhesive film, then centrifuge briefly to bring the reaction mix
to the bottom of the well and eliminate air bubbles.
IMPORTANT! Use a MicroAmp™ Optical Film Compression Pad when using:
· MicroAmp™ Optical 96‑Well Reaction Plate on the 7900HT Real‑Time PCR
Instrument
· MicroAmp™ Optical 96‑Well Reaction Plate or MicroAmp™ Optical 384‑Well
Reaction Plate on the GeneAmp™ PCR System 9700
Set up the PCR IMPORTANT! This procedure is optimized for TaqMan® Genotyping Master Mix. See
reactions: Table 16 on page 21 for alternative master mixes and plate and cycling conditions.
dried‑down DNA
method
Prepare the reaction mix: dried‑down DNA method
1. Calculate the number of reactions to be performed for each assay, including
recommended controls (see “Prepare assays, DNA samples, and master mix“ on
page 18).
Note: Multiple assays can be run on one reaction plate. Controls for each assay
must be included on the same plate.
2. Combine the following components for the number of reactions required, plus
10% overage.
4. Centrifuge briefly to bring the reaction mix to the bottom of the tube and
eliminate air bubbles.
3. Add the appropriate volume of reaction mix to each well of the reaction plate
(see Table 16 on page 21).
4. Seal the plate with optical adhesive film, then centrifuge briefly to bring the
reaction mix to the bottom of the well and eliminate air bubbles.
IMPORTANT! Use a MicroAmp™ Optical Film Compression Pad when using:
· MicroAmp™ Optical 96‑Well Reaction Plate on the 7900HT Real‑Time PCR
Instrument
· MicroAmp™ Optical 96‑Well Reaction Plate or MicroAmp™ Optical 384‑Well
Reaction Plate on the GeneAmp™ PCR System 9700
Perform PCR
IMPORTANT! This procedure is optimized for TaqMan® Genotyping Master Mix. See
Table 13 on page 17 for alternative master mixes and plate and cycling conditions.
Note: (Optional) Perform PCR in real‑time experiment mode. Real‑time PCR allows
observation of genotyping data over time to evaluate the accuracy of genotype calls
by observing the location of a given sample relative to others throughout all cycles. If
the quantity of DNA added is too high, resulting in merged genotyping clusters, the
experiment can be reanalyzed at fewer cycles to recover genotyping accuracy.
Software Features
Real-time • Instrument software
instrument • View real‑time trace data to aide genotype calling
software
Data analysis varies depending on your real-time PCR system.
See the instrument User Guide for more information.
TaqMan® Genotyper • Desktop software
Software • Create studies
• Overlay data from multiple plates
See “Data analysis with TaqMan® Genotyper Software“ on
page 24.
Thermo Fisher • Cloud software
Cloud Genotyping • Create studies
Application
• Overlay data from multiple plates
• View real-time trace data to aide genotype calling
See “Data analysis with the Thermo Fisher Cloud Genotyping
Application“ on page 25.
Note: TaqMan® Genotyper Software and the Thermo Fisher Cloud Genotyping
Application use algorithms that yield more accurate genotype calls and quality
control functionality than instrument analysis software.
4. Make automatic or manual allele calls. See “Allelic discrimination plots“ on
page 26 for more information.
5. Verify allele types.
Data analysis with TaqMan® Genotyper Software is a standalone software application that can be used to
TaqMan® analyze raw data from genotyping experiments created on an Applied Biosystems™
Real‑Time PCR system.
Genotyper
Software The TaqMan® Genotyper Software can be used to:
• Create a study:
– Import multiple experiments into a single study
– Import assay information files (*.txt or *.xml) to update assay
information
– Define analysis settings
– Import Supplementary Sample Information (SSI) files to update sample
information such as gender or population
– Import reference panel files to add reference samples to a study
• Generate a study template, then use the study template to create new studies. The
software analyzes the data according to the analysis settings that were defined in
the study template.
• Analyze the study data using one of two call methods:
– Autocalling—The software algorithm is used to call the data points.
– Classification Scheme—You define the cluster boundaries that are used to
call the data points.
• View the study results; for example, a summary of the Quality Control (QC)
statistics at the study level, assay level, experiment level, and sample level.
• Export the following data:
– Analysis results
– Analysis settings
– Audit trails
• Transfer studies from one TaqMan® Genotyper Software application to another.
• Ensure data security. The security feature allows you to:
– Set security parameters to manage users (set up user accounts and assign
user roles)
– Track changes to the data
For more information on using TaqMan® Genotyper Software, see the TaqMan®
Genotyper Software Getting Started Guide (Pub. No. 4448637).
Data analysis with The Thermo Fisher Cloud Genotyping Application is a stand‑alone software
the Thermo Fisher application that can be used to analyze raw data from genotyping experiments that
are created on an Applied Biosystems™ real‑time PCR system.
Cloud Genotyping
Application Use the Thermo Fisher Cloud Genotyping Application to:
• Create a study:
– Import multiple experiments into a single study.
– Import data from probes that are labeled with FAM™, VIC™, ABY™, or JUN™.
– Import assay information files (*.txt or *.xml).
– Define the analysis settings.
– Import Supplementary Sample Information (SSI) files to update sample
information such as gender or population.
– Import reference panel files to add reference samples to a study.
• Analyze study data using one of two call methods:
– Autocalling—The software algorithm is used to call the data points.
– Classification Scheme—User-defined cluster boundaries are used to call the
data points.
• Analyze a subset of data by creating analysis groups with a subset of data files or
samples. Each analysis group has its own set of analysis settings and analysis
results. The analysis group table displays the analysis status for each group.
• View real‑time data, including amplification plots, multi component plots, and
traces of individual samples for a given assay by cycle in allelic discrimination
plots.
• View the study results. For example, a summary of the Quality Control (QC)
statistics at the study level, assay level, experiment level, and sample level.
• Export the following data:
– Analysis results
– Analysis settings
– Genotype call settings
– Flag settings
– Genotype matrix of samples vs. assays
Allelic TaqMan® Genotyper Software, the Thermo Fisher Cloud Genotyping Application, and
discrimination real‑time PCR instrument software plot the results of the allelic discrimination data as
a plot of Allele 1 (VIC™ dye) versus Allele 2 (FAM™ dye). The allelic discrimination
plots
(AD) plot, also known as a cluster plot or scatter plot, represents each sample well as an
individual point on the plot.
A typical AD plot shows Homozygote clusters, a Heterozygote cluster, and the no‑
template controls. The points in each cluster are grouped closely together and each
cluster is located well away from the other clusters. See Figure 1 and Table 17 on
page 27 for expected cluster locations in an AD plot.
s
his SVG.
uts or arrows
Arrow_Libary. The clusters are cloudy or diffuse Sample preparation errors
ed. Sample DNA is degraded. See “Degraded DNA“ on
page 45.
sed
1
Assay preparation errors
ROX™ dye was not present in See “Using a master mix
the PCR Master Mix. without ROX™ dye“ on
page 48.
There was evaporation from See “Evaporation from the
the reaction well. reaction well“ on page 49.
There were pipetting errors. See “Pipetting errors“ on
page 49.
Instrument set-up and
maintenance errors
ROX™ dye was not designated See “ROX™ dye not
as the reference dye. designated as a passive
reference“ on page 55.
If only one cluster is present, See “Single cluster assay“ on
the allelic discrimination plot page 55.
was incorrectly scaled.
Low allele Only one or two clusters can occur in the AD plot, as shown in Figure 2, when the
frequency minor allele occurs at a low frequency in the population being studied.
ows
bary.
Figure 2 Allelic discrimination plot shows a single cluster (in addition to the NTCs).
What to do
1 To determine if the size of your sample population is sufficient to detect the minor
allele of interest:
1. Find the MAF for your assay on the TaqMan® SNP Genotyping Assays page at
thermofisher.com/taqmansnp, which is frequently updated.
Alternatively, the MAF is in the Assay Information File that is distributed with
the assays. Allele frequency data can also be found using the public SNP
identifier, from public websites such as:
a. The dbSNP index at http://www.ncbi.nlm.nih.gov/SNP/index.html
b. The 1,000 Genomes project at www.1000genomes.org
2. Using the Hardy‑Weinberg Equilibrium equation, determine if the minor allele is
detectable for a sample the size of your test population (see “Example
calculation“ on page 37).
In the Hardy‑Weinberg Equilibrium equation, q2 + 2qp + p2 = 1, the expected
genotype frequencies are q2, 2qp, and p2, where q and p represent the allele
frequencies.
The values for q2, 2qp, and p2 correspond to the fraction of a population that
would be homozygous for the minor allele (qq), heterozygous (qp), and
homozygous for the major allele (pp), respectively.
3. Multiply your sample size by the fraction for each allele to determine the number
of individuals with each genotype that you expect to see.
If your sample size is small, you might not be able to detect rare alleles.
Example calculation
For an SNP with a MAF of 5% (0.05), the predicted frequencies are 0.0025 q:q, 0.095
q:p, and 0.9025 p:p.
If you test 20 genomic DNA samples from this population, you might expect:
• Homozygotes for the minor allele—0.0025 × 20 = 0.05, no individuals
• Heterozygotes—0.095 × 20 = 1.9, about 2 individuals
• Homozygotes for the major allele—0.9025 × 20 = 18.05, about 18 individuals
To detect one homozygote for the minor allele, it would take a sample size of
approximately 400 individuals (Sample Size = 1/MAF2)
Discussion
Many assays in TaqMan® SNP and DME Assays collection show low or 0 for the
minor allele frequency. Many of these SNPs are believed to be functional
polymorphisms that can occur at low frequencies, depending on the population you
are studying. The MAF indicates the frequency of the less‑frequent allele in a
population. Traditionally, only the minor allele frequency is reported. The major allele
frequency is calculated as 1 - MAF. From the MAF, you can calculate how large the
sample population should be to detect a specific allele. The lower the frequency of the
minor allele, the larger the sample size that is required to detect the allele.
Deletion alleles in When an individual does not have the gene or the portion of the gene that contains
an individual the SNP of interest, the data point in the allelic discrimination plot will either:
• Appear as a homozygote of the allele that is present (where there is one deletion
allele)
• Cluster with the NTCs (when there are two deletion alleles)
If an individual sample consistently clusters with the NTCs for a particular assay, it
may indicate the individual has a deletion allele. There are documented occurrences
of copy number variation and deletion alleles in the genes CYP2A6 , GSTM1 , GSTT1 ,
SULT1A1 and CYP2D6 in the TaqMan® DME Genotyping Assays collection.
Uncalled samples
indicated by Xs
NTCs indicated by
squares
Area of plot around
NTC, zoomed in
Figure 3 Allelic discrimination plot showing a deletion allele for the assay
C__8717770_20.
What to do
1. Evaluate the overall assay performance:
• Do the assay results appear in tight clusters?
• Do the clusters have good separation?
2. Repeat the experiment. If the same sample(s) consistently cluster with the NTC
while other samples show fluorescence, a deletion allele may be present.
3. Examine the sample's performance in other assays to rule out problems caused
by this particular sample, such as sample impurity or degradation.
Additional SNP A non‑target SNP under a primer or probe can result in off-cluster data. The location
present under a of the non‑target SNP under the primer or probe, as well as the MAF, influences the
extent to which the cluster pattern is atypical. The number of individuals exhibiting
probe or primer
this pattern depends on the allele frequency of the non‑target SNP. A SNP under a
probe can result in an outlier that falls between the heterozygote and one of the
homozygotes (an angle cluster), due to a lack of amplification of the sample when
there is an additional polymorphism under the primer (Figure 4). The presence of a
polymorphism under a primer generally leads to lower PCR efficiency.
and Arrows
arrow to use in this SVG.
length, as needed.
1
Figure 4 Additional SNP under a primer. The points in black between the green and red
clusters constitute angle clusters.
A SNP under a probe can also result in an outlier that has the same angle as a cluster
but trails behind the main cluster (a vector cluster). You may see points that are in
agreement with a cluster but trail behind the main cluster (a "vector cluster") when
there is an additional SNP under the probe (Figure 5). The presence of a SNP under a
probe leads to lower fluorescence intensity.
SNP under probe circled in red. The points trailing behind the main clusters are vector clusters.
What to do
To confirm the presence of another SNP under the probe or primer:
1. Repeat the experiment, then evaluate overall assay performance.
• Do the assay results appear in tight clusters?
• Do clusters have good separation?
2. Verify the presence of the outlier.
3. Examine the sample's performance in other assays to rule out problems caused
by this particular sample, such as sample impurity or degradation.
4. Search the public databases, such as dbSNP, to see if the additional SNP has been
discovered.
5. Perform comparative sequencing on the subjects to identify any undocumented
SNPs present under the primer or probe. The presence of extra SNPs may cause
angle clusters or vector clusters.
Discussion
Our assay design process included many checks to assure that primers and probes
were not designed over significant polymorphisms other than the intended SNP
target. However, the growing number of SNPs discovered in studies of different
ethnic populations make it possible that some of the primers and/or probes in the
TaqMan® SNP and DME Genotyping Assays may overlap currently unknown
polymorphisms in certain populations. In some rare cases, there are some assays
where primers and probes are located over SNPs or other polymorphisms due to the
close proximity of the two SNPs. For these assays, the vector cluster falls in line with
samples of the same genotype, but the reduced PCR efficiency causes a reduction in
signal intensity.
Gene has a copy A copy number polymorphism for a gene may or may not appear as an anomaly in
number the allelic discrimination plot.
polymorphism • If an individual is homozygous with more than three copies of the gene and each
copy has the same genotype, the data will most likely appear in the homozygous
cluster.
• If an individual is heterozygous with an odd number of copies and the copies
have different genotypes, then the data will probably fall between the clusters for
the heterozygote (T:A) and the homozygote (A:A).
Several of the genes included in the TaqMan® Genotyping and DME Assays are
known to have copy number polymorphisms: CYP2D6, GSTM1, GSTT, CYP2E1, and
CYP2A6.
6. Perform analysis using a TaqMan® Copy Number Assay (Cat. No. 4400291) on all
samples to determine the copy number for the gene in which the polymorphism
resides.
• The Copy Number Assay of interest can be found at thermofisher.com/
taqmancnv.
• A Custom TaqMan® Copy Number Assay can be designed if a pre‑designed
TaqMan® Copy Number Assay does not exist for a target of interest.
• A TaqMan® Copy Number Assay must be run in duplex with a reference
assay. Reference assays are commercially available for human and mouse
analysis. If working with other species, you need to identify and use your
own reference assay target.
Discussion
Data points for samples from homozygous individuals with extra copies of a gene
will generally cluster with the homozygous cluster. Data points for heterozygous
individuals with copy number polymorphisms may appear as outliers such as a
fourth or fifth cluster between the heterozygote cluster and one of the homozygous
clusters. Since a copy number variation may not present itself in all individuals, a
gene dosage assay should be performed on all samples to determine which
individuals carry extra copies of the gene.
SNP is triallelic When an SNP is triallelic, you may see outlier samples in the allelic discrimination
plot, although the samples may not be well separated from the main clusters. These
situations are best confirmed by running replicate plates. We provide pairs of
TaqMan® SNP Genotyping Assays to several important DME and CFTR gene variants
that are triallelic (see the Pharmacogenomics Experiments Application Guide (Pub. No.
MAN0009612) and the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
Genotyping Experiments User Guide (Pub. No. MAN0014405).
What to do
1. Evaluate overall assay performance: Are there consistent outlier samples?
2. Examine the sample performance in other assays to rule out problems that are
caused by this particular sample, such as sample impurity or degradation.
3. Perform comparative sequencing on the subjects to verify the presence of more
than two alleles.
4. Repeat the experiment. If the same samples are consistently in the same outlier
space (away from the NTCs, the heterozygotes, and the homozygotes) your gene
may be triallelic.
5. Check the literature for the SNP in question. There may be newly reported
polymorphisms that are described in the literature. Calculate the allele
frequencies for your plate and compare them to the literature to confirm your
results agree with the literature.
Discussion
If an SNP is triallelic, you might see six clusters (three homozygotes and three
heterozygotes) instead of the typical pattern of three clusters (two homozygotes and
one heterozygote). Figure 6 and Table 18 show the possible genotypes that are
associated with SNP rs2032582 in the ABCB1 gene that is known to have three alleles
in several populations. Note that the alleles reported by the ABCB1 SNP assays are
given in the (+) strand genome orientation whereas the ABCB1 gene maps to the (−)
genome strand. Thus, the reported SNP assay alleles and the SNP cDNA annotations
are the reverse complement of one another.
Figure 6 Allelic discrimination plot for triallelic SNP rs2032582. (Left) ABCB1 c.3095G>A assay (C_11711720D_40) to
the plus strand C wild type and T mutant allele. (Right) ABCB1 c.3095G>T assay ( C_11711720C_30 ) to the C wild type
and A mutant allele.
Table 18 Translation table for the ABCB1 c.3095G>T/A triallelic SNP rs2032582
assays
Gene on the X When a gene is on the X chromosome and the population being studied is made up of
chromosome both males and females, the genotype frequencies of the samples do not correspond to
the predicted autosomal Hardy‑Weinberg frequencies. For a sample population
composed of a mixture of males and females, the number of heterozygotes will be
noticeably lower than predicted by the Hardy‑Weinberg equilibrium equation. None
of the males should be heterozygous because males have only one X chromosome.
Figure 7 Allelic discrimination plot with a small number of heterozygotes for a gene on
the X chromosome
What to do
1. Check the AIF included with the assay or the TaqMan® SNP or DME Genotyping
Assays pages (thermofisher.com/taqmansnp or thermofisher.com/taqmandme)
to determine if the assay is for a target located on the X chromosome.
2. Check your results by gender.
Discussion
When a SNP is located on the X chromosome, only the females in the population can
be heterozygous. Males, with only one X chromosome, will always be homozygous.
Depending upon the minor allele frequency, you may see males in only one of the two
homozygous forms.
Gene on the Y When a gene is on the Y chromosome and the population is made up of both males
chromosome and females, female samples will appear with the NTC samples. This result does not
reflect assay performance but is due to the fact that female samples will not amplify.
As result, only two clusters will be visible because males have only one Y
chromosome. In Figure 8, female samples are yellow.
Degraded DNA Degraded DNA can affect PCR efficiency due to the presence of fewer template
copies. Degradation can result from:
• Using very old DNA samples
• Using DNA extracted from formalin-fixed paraffin embedded samples
• Freezing and thawing DNA samples repeatedly
• Leaving DNA samples at room temperature
• Exposing DNA samples to heat, physical shearing, or UV light in ambient
lighting
• Purifying DNA samples inefficiently so residual nucleases remain
What to do
• Run an agarose gel to determine if your DNA is degraded. Look for a tight band
of high molecular weight. Smearing indicates degraded DNA. Figure 9 illustrates
DNA degraded by heat.
30 seconds
10 minutes
15 minutes
30 minutes
Size stnd.
5 minutes
3 minutes
0 second
1 minute Sample A
Sample B
Figure 9 Agarose gel stained with ethidium bromide showing two samples of human
gDNA subjected to heating at 99°C for 0 to 30 minutes.
• If the DNA is substantially degraded, use more caution in interpreting your
results. If possible, consider repeating the assay using freshly prepared genomic
DNA samples.
• For future experiments, follow the sample storage guidelines in Table 19.
Discussion
Because the average size of the DNA in a degraded sample approaches the size of the
target sequence, the amount of PCR product generated is reduced because there are
fewer intact templates in the size range necessary for amplification.
PCR inhibitors in Potential PCR inhibitors can originate from the tissue source of the DNA sample or
sample from the purification method. Inhibitors originating from the cell include heparin,
proteins, and heme. Inhibitors originating from DNA preparation include phenol,
proteases, detergents (SDS), and salts (EDTA and citrate).
The presence of polymerase inhibitors can decrease PCR efficiency, leading to:
• Trailing clusters
• Nonamplification such that some (or all) samples cluster with the NTCs
What to do
• Dilute the sample and run the assay with the diluted sample. If the inhibition
decreases, then it is likely there are PCR inhibitors in the sample.
• Repurify the sample and run the assay again.
• Consider using a master mix more tolerant to inhibitors such as TaqPath™
ProAmp™ Master Mix.
Discussion
Inhibition of PCR is always possible when DNA is extracted from tissue and/or blood
samples.
Because DNA purification method that is used to prepare gDNA can affect the
success of PCR, the selected method must minimize degradation and remove
inhibitors. One method for evaluating DNA purity is to calculate the A260 /A280 ratio.
In addition, absorbance at 230 nm can indicate the presence of phenol. See “UV
spectroscopy“ on page 62 for more information.
Assay consideration
• Store TaqMan® Assays between –15 and –25°C when they are not in use.
• Minimize freeze‑thaw cycles to no more than ten cycles. Too many freeze thaw
cycles can cause cleavage of the dye from the probe.
• Limit the assay exposure to light. The fluorescent dyes are susceptible to photo‑
bleaching. Photo‑bleaching can result in a lower overall signal for the reaction.
TaqMan® Genotyping Master Mix considerations
• Store TaqMan® Genotyping Master Mix at 2–8°C.
• Make sure the master mix is thoroughly mixed prior to use.
Using a master The use of a PCR Master Mix that does not contain ROX™ dye (or a similar passive
mix without ROX™ reference) can cause:
dye • Trailing clusters
• Undetermined data (an "X" instead of a called allele in the AD plot)
• Diffuse clusters
What to do
Use a TaqMan® Genotyping Master Mix which includes ROX™ dye.
Discussion
ROX™ dye is a passive reference dye that improves the precision of the results by
compensating for small fluorescent fluctuations, such as bubbles and small well‑to‑
well variations.
Our analysis software for allele discrimination and genotyping experiments will not
call the alleles when ROX™ dye (or another passive reference) is not present.
See “ROX™ dye not designated as a passive reference“ on page 55 for more
information.
DNA or assay When gDNA or one of the assay reagents is not added to the reaction well, no PCR
reagent not added amplification takes place and the sample clusters with the NTCs.
to the reaction What to do
well Perform the assay again, making sure to:
• Follow the TaqMan® SNP Genotyping Assay protocol exactly.
• Pipette carefully.
• Mix thoroughly.
Insufficient DNA When insufficient gDNA is added to the reaction well, no PCR amplification takes
added to the place and the sample clusters with the NTCs.
reaction well What to do
Perform the assay again, making sure to:
• Quantitate your DNA accurately (see “Quantify the sample gDNA“ on page 18).
• Follow the TaqMan® SNP Assays protocol as recommended, adding 1–20 ng of
purified genomic DNA (ensuring final concentration no less than 0.2 ng/µL).
• Pipette carefully.
• Mix thoroughly.
Evaporation from Evaporation of your reaction can occur if the reaction plates are not properly sealed,
the reaction well leading to:
• Outliers (mild/moderate evaporation)
• Trailing clusters (moderate evaporation)
• Samples clustering at the NTC (extreme evaporation)
What to do
1. Check the location of the wells for the problem calls. Evaporation can most often
occur around the edges of the plate.
2. Check the seals of the optical adhesive cover for leaks.
3. If there are leaks, perform the assay again.
Use a MicroAmp™ Adhesive Film Applicator (Cat. No. 4333183) to thoroughly seal
the cover. Make sure to run the applicator over the edges of the seal.
Discussion
Evaporation can occur if your plate is not properly sealed. As evaporation occurs, the
water in the reaction decreases, causing the signals from the reporter and ROX™ dyes
to increase due to increased concentration of the dyes. The degree of evaporation
influences the assay results:
• Mild — If the PCR reaction is not affected, the ROX dye can compensate for the
increased signals and the assay will work correctly.
• Mild to moderate — You may see outlier samples. Depending on the number of
wells affected, the plot may show only a few outliers or it may show a trailing
cluster.
• Extreme evaporation occurring early in the reaction — The PCR reaction fails and
the samples cluster with the NTC.
Pipetting errors Pipetting errors can cause inconsistent delivery of reagents or sample to the wells,
which can cause:
• Trailing clusters
• Some (or all) samples clustering with the NTCs
• Cloudy or diffuse clusters
• One or more samples that do not cluster with a specific allele (i.e. an outlier)
What to do
• Improve pipetting precision, using the following techniques:
– Calibrate and clean the pipettors regularly.
– Pipette larger volumes (no less than 5 µL) for greater accuracy and precision.
– Reduce the number of pipetting steps whenever possible.
– Increase the consistency of the pipetting method (such as using robotic
pipetting).
– See the manufacturer instructions for the correct method of dispensing liquid
volumes accurately from the pipettor. For example, some pipettors are
designed to deliver the designated volume at the first plunger stop, so
blowing out the remaining volume can cause errors.
• Check your pipetting process by preparing a replicate plate (same assay and
sample over a plate) to be sure that results are reproducible.
Inefficient mixing Insufficient mixing or centrifugation can cause trailing clusters in the AD plot.
or centrifugation What to do
Rerun the assay, mixing the samples well (by pipetting up and down a few times) and
performing the centrifugation steps as described in the protocol. Centrifuging the
samples ensures that the contents of the sample well are pooled at the bottom of the
well, allowing for the most efficient PCR reaction and the most accurate endpoint
read.
Assay has high Some assays have higher levels of background fluorescence than others which can
background cause:
fluorescence • The position of the NTCs moving away from the origin of the allelic
discrimination plot
• The position of the homozygous cluster moving towards the heterozygous
clusters
What to do
If the clusters are well separated from each other, TaqMan® Genotyper Software or the
Thermo Fisher Cloud Genotyping Application can autocall the clusters. You can also
manually call the clusters.
More than one Sometimes samples are inadvertently mixed together due to poor lab technique,
sample in the well resulting in an outlier.
Figure 10 Allelic discrimination plot with different samples in the same well (outlier
sample circled in red)
What to do
Perform the assay again making sure that two samples are not combined in the same
wells.
More than one Sometimes assays are inadvertently mixed together due to poor lab technique,
assay in the well resulting in more than 3 clusters in a plot.
ws
n this SVG.
outs or arrows
&Arrow_Libary.
ded.
used
ts
ry.
Figure 11 Allelic discrimination plot with different assays in the same well
What to do
Perform the assay again making sure that two assays are not combined in the same
wells.
Routine To ensure optimal performance of your thermal cycler or real‑time PCR system, we
instrument strongly recommend that you perform routine maintenance. Maintenance schedules
vary by instrument; refer to your relevant instrument manual for details.
maintenance
Instrument We recommend that you regularly calibrate your thermal cycler or real‑time PCR
calibration system to ensure optimal performance. Calibration varies by instrument. See your
specific instrument user guide for details.
Types of
calibration ROI calibration
ROI calibration allows the Real Time PCR Instrument Software to map the position of
the wells on the sample block so that, during instrument operation, the software can
associate increases in the fluorescence with specific wells of the reaction plates.
Background calibration
The background calibration measures the ambient fluorescence that is generated from
background electrical signals, sample blocks, water inside consumables, and from the
consumables themselves. This calibration enables the Real Time PCR Instrument
Software to eliminate background signal from the fluorescent samples, thus increasing
the precision of the instrument.
Empty allelic Incorrectly creating and/or selecting the detector and marker can result in an empty
discrimination allelic discrimination plot even when the assay chemistry is successful.
plots When the allelic discrimination plot is empty, causes include:
• “No assay or marker assigned to the well“ on page 54
• “Omit option checked in Real Time PCR instrument software“ on page 54
• “ROX™ dye not designated as a passive reference“ on page 55
No alleles called To assist with cluster calling, the Real Time PCR Instrument Software can autocall the
in the AD plot data. When autocalling fails, you will see "X" on the plot rather than the symbol for
called alleles. There are some instances where the software will not autocall the data:
• “Autocall is not selected“ on page 54
• “Two cluster calling not selected“ on page 54
• “Single cluster assay“ on page 55
• “ROX™ dye not designated as a passive reference“ on page 55
• “Outlier too far off scale“ on page 56
• “NTCs not assigned“ on page 57
Homozygous Your observed major and minor allele frequencies for homozygotes are reversed from
allele frequencies those predicted by the Hardy‑Weinberg Equilibrium equation. For example, for a SNP
with a MAF of 5% (0.05), the predicted frequencies are 0.0025 q:q, 0.095 q:p, and
reversed
0.9025 p:p. If the allele frequencies are reversed, you see 0.9025 q:q, 0.095 q:p, and
0.0025 p:p.
Reporter dye assigned incorrectly to the allele in the detector
In the software, you must set up two detectors and one marker in order for the alleles
to be called. The detector defines which dye is assigned to the allele. If you
inadvertently assigned the dyes to the wrong alleles when you created the detectors,
the observed frequencies will be the reverse of those predicted from the Hardy‑
Weinberg equation.
Note: The AIF included with your order contains the correct allele‑dye assignments.
Too many alleles In the software, you must set up one marker for each assay run on the plate. Running
called in AD plot more than one assay per marker can result in more than three clusters in the allelic
discrimination plot.
The same markers and detectors are assigned to two The same markers and detectors are assigned to one of
assays the two assays
Figure 15 Allelic discrimination plots showing two assays assigned to one detector and
marker.
What to do
1. Create markers and detectors for each assay on the plate. Refer to the instructions
in your instrument manual appropriate for your software.
2. Assign each marker to the correct assays.
3. Re‑analyze your data.
Multiple assays may be run on a single plate, however it is essential that each assay is
assigned its own marker. Each assay has its own unique run characteristics. Running
two assays with the same marker name may result in genotyping miscalls and the
appearance of assay failure.
th, as needed. 1
About the 5' Note: The following figures are general representations of PCR with TaqMan® MGB
e, and unused
nuclease assay probes and TaqMan® SNP Genotyping Assays. The sequence regions are not
G elements necessarily drawn to scale. The principals of the assay are the same for TaqMan®
e repository.
QSY™ probes.
The 5' nuclease assay process takes place during PCR amplification. It occurs in every
1 cycle and does not interfere with the exponential accumulation of product.
1 For the PCR amplification, genomic DNA is introduced into a reaction mixture
consisting of master mix, forward and reverse primers, and two TaqMan® probes
Figure 17.
Minor Groove
V VIC™ dye MGB Binder Probe
Figure 16 Legend
B B
MG MG
Forward primer Probe 1 Probe 2 Reverse primer
V Q F Q
A G
1 5' 3'
B B
MG Probe 2 MG Reverse primer
Probe 1
V Q F Q
Forward primer A G
[C/T]
3' 5'
1 1
Appendix B Supplemental information
DNA quantification B
1
requirements, nonspecific amplification is not detected, and the fluorescence signal
indicates which alleles are in the sample (Table 20).
B 5' 3'
Probe 1 MG
F Q
Reverse primer
A
C
Match
DNA quantification
In an assay and/or study, gDNA concentration uniformity leads to accurate, robust,
and reproducible results and ensures efficient use of valuable samples. Precise
handling and quantitative measurements before running an assay can prevent errors
without waste of reagents and samples.
Variability in gDNA concentrations in TaqMan® SNP Genotyping Assays can lead to
experimental anomalies that can affect interpretation of genotyping results, including:
• Trailing clusters
• Some (or all) samples clustering with the NTCs
• Cloudy or diffuse clusters
• A sample (or samples) does not cluster with a specific allele (i.e. is an outlier)
127 ng
10 ng
5 ng
135 ng
5 ng
NTC 0.5 ng
All samples have 3 ng gDNA Samples with gDNA ranging from 0.5 to 127 ng
®
Figure 20 Allelic discrimination plots for TaqMan DME Genotyping Assay
C__1204092_20.
To ensure accurate results:
• Always perform your own concentration measurements before using any
genomic DNA (gDNA), even commercially prepared DNA.
• Use the recommended amount of gDNA, 1–20 ng per sample per assay.
• Always use the same quantity of gDNA for all samples of an assay on a plate.
There are numerous methods for quantitating genomic DNA, including:
• UV spectroscopy
• Absolute quantification
– TaqMan® RNase P method
– SYBR™ Green assay
• Fluorometric analysis
We recommend quantifying gDNA using UV spectroscopy or absolute quantification
using the TaqMan® RNase P method.
Absolute Absolute quantification measures the total amount of amplifiable gDNA. This
quantification technique requires the creation of a standard curve using gDNA samples of known
quantities. The standard samples must be pre-quantified and confirmed using an
independent method such as spectrophotometry or fluorometry. The unknown
samples are compared to the known samples for quantification.
Absolute
quantification Description
method
TaqMan® RNase P TaqMan® RNase P is a highly accurate 5' nuclease assay that
detects and quantifies genomic copies of the human RNase P
gene. TaqMan® DNA Template Reagents (Cat. No. 401970) and
TaqMan® RNase P Detection Reagents Kit (Cat. No. 4316831) allow
for convenient means to quantify gDNA. See RNase P
Quantification for Genotyping Experiments
(Pub. No. MAN0014349 ) for more information.
SYBR™ Green assay SYBR™ Green dye binds to double-stranded DNA (dsDNA).
Quantification with theSYBR™ Green assay is less specific than
TaqMan® RNase P because the dye binds to any dsDNA whereas
TaqMan® reagent chemistry targets a specific DNA sequence. The
SYBR™ Green method requires melt curve analysis to ensure the
specificity of the assay.
For either technique, run the standard curve and unknown samples on the same
plates in the real‑time PCR instrument.
Fluorometric You can quantify DNA by fluorometric analysis using the Qubit™ 3.0 Fluorometer or
analysis various intercalating dyes.
Chemical safety
WARNING! GENERAL CHEMICAL HANDLING. To minimize hazards,
ensure laboratory personnel read and practice the general safety guidelines for
chemical usage, storage, and waste provided below. Consult the relevant SDS
for specific precautions and instructions:
· Read and understand the Safety Data Sheets (SDSs) provided by the
chemical manufacturer before you store, handle, or work with any chemicals
or hazardous materials. To obtain SDSs, see the “Documentation and
Support” section in this document.
· Minimize contact with chemicals. Wear appropriate personal protective
equipment when handling chemicals (for example, safety glasses, gloves, or
protective clothing).
· Minimize the inhalation of chemicals. Do not leave chemical containers open.
Use only with adequate ventilation (for example, fume hood).
· Check regularly for chemical leaks or spills. If a leak or spill occurs, follow
the manufacturer's cleanup procedures as recommended in the SDS.
· Handle chemical wastes in a fume hood.
· Ensure use of primary and secondary waste containers. (A primary waste
container holds the immediate waste. A secondary container contains spills
or leaks from the primary container. Both containers must be compatible
with the waste material and meet federal, state, and local requirements for
container storage.)
· After emptying a waste container, seal it with the cap provided.
· Characterize (by analysis if necessary) the waste generated by the particular
applications, reagents, and substrates used in your laboratory.
· Ensure that the waste is stored, transferred, transported, and disposed of
according to all local, state/provincial, and/or national regulations.
· IMPORTANT! Radioactive or biohazardous materials may require special
handling, and disposal limitations may apply.
Related documentation
PDF versions of this guide and the documents listed in this section are available at
thermofisher.com/support.
Note: To open the user documentation, use the Adobe™ Reader™ software available
from www.adobe.com.
L
B
limited product warranty 69
biohazard safety 66
M
C
Minor‑groove binder (MGB), Probe 6
Chromosome Minor‑groove binding (MGB), Probe 59
X 35
Y 35
Cluster N
Diffuse 47, 51 Nonfluorescent quencher (NFQ) 6
Trailing 47, 51
Context sequence 7
Custom Assay Design Tool (CADT) 9, 11 O
Outliers 47, 53
D
DNA P
Degradation 45 PCR inhibition 45
Quantitation 45 Pre‑PCR plate read 22
DNA delivery Probe hybridization 59
Dried‑down DNA 19
Wet DNA 19
documentation, related 67 Q
Drug Metabolism (DME) Index 11 QSY quencher 9
Qualified assay 8
R U
related documentation 67 UV spectroscopy 45
Rescaling 53
V
S Validated assay 8
safety, biohazard 66 VIC dye 6, 25, 59
Single nucleotide polymorphism (SNP) 6
Supplementary Sample Information (SSI) 24
support, customer and technical 68 W
warranty 69
T
terms and conditions 69
Thermo Fisher Cloud Genotyping Application 23,
25
29 September 2017